Hirotaka Tomiyasu

10PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCharacterisation of biological macromoleculesTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 13, 2025
In response to 'Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study' by Treggiari et al.

A Ohmi, T Motegi, H Tomiyasu

|Jun 12, 2025
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells.

Hiroki Sakuma, Hirotaka Tomiyasu, Akiyoshi Tani

|Dec 04, 2023
Polyoxazoline-Conjugated l-Asparaginase: An Antibody-Production-Free Therapeutic Agent for Acute Lymphoblastic Leukemia.

Taiga Yamada, Marika Ishimaru, Takuma Shoji

|Apr 23, 2023
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease.

Mona Uchida, Yuki Matsumiya, Masaya Tsuboi

|Mar 12, 2022
mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders.

Miyuki Hirabayashi, James K Chambers, Akiyoshi Tani

|Jul 12, 2021
Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T-cell lymphomas.

Kazushi Azuma, Aki Ohmi, Yuko Goto-Koshino

Pageof 2

Frequent Collaborators

4 joint publications

Aki Ohmi

3 joint publications

Tomoki Motegi

3 joint publications

Hajime Tsujimoto

2 joint publications

Kazuyuki Uchida